Letters (Westmoreland)

Letter to the editor: They’re coming for your supplements

Tribune-Review
By Tribune-Review
2 Min Read July 3, 2022 | 3 years Ago
Go Ad-Free today

Get ready people, the feds are coming for your supplements again. Your health rights to buy supplements are about to be robbed from you, and as usual no mainstream news media reporting. The senator responsible is anti-supplement Sen. Dick Durbin, D-Ill. We beat back this nonsense before, and we can do it again, but Congress must hear from you.

The nonsense legislation in question is S.4090, the Dietary Supplement Listing Act of 2022. The bill is nonsense and absurd, and that they know it won’t pass by itself, so Sen. Patty Murray, D-Wash., snuck it into must-pass legislation, the Prescription Drug User Fee Act. The bill will create a huge database of supplements, making it much easier for FDA to start yanking them off the shelves.

This bill is really about only one thing, huge profits for the pharmaceutical industry. S.4090 also targets high-dose supplements, so if this passes, try to get 500mg vitamin C. The future of supplements is real clear if S.4090 passes: About all you will find in health food stores is One-A-Days and granola bars.

We already told Congress no when they tried to get our supplements in the past. What part of no does Congress not understand?

Don’t let the FDA tramp on your rights to buy supplements. Call or email Congress, especially the Senate, and tell them to vote no on S.4090.

Lance M. Martin

Belle Vernon

Share

Tags:

About the Writers

Push Notifications

Get news alerts first, right in your browser.

Enable Notifications

Content you may have missed

Enjoy TribLIVE, Uninterrupted.

Support our journalism and get an ad-free experience on all your devices.

  • TribLIVE AdFree Monthly

    • Unlimited ad-free articles
    • Pay just $4.99 for your first month
  • TribLIVE AdFree Annually BEST VALUE

    • Unlimited ad-free articles
    • Billed annually, $49.99 for the first year
    • Save 50% on your first year
Get Ad-Free Access Now View other subscription options